Compound amino acid injection, a subsidiary of Tianjin Pharmaceutical (600488.SH), obtained a drug registration certificate

Zhitong Finance App News, Tianjin Pharmaceutical (600488.SH) issued an announcement. Recently, the company's subsidiary Hubei Jinyao Pharmaceutical Co., Ltd. received the “Drug Registration Certificate” for compound amino acid injections (18AA-VII) approved and issued by the State Drug Administration. Compound amino acid injection (18AA-VII) is used for hypoproteinemia, undernutrition, and amino acid supplementation before and after surgery. The drug is declared according to the 4 types of chemical registration. After approval, it is treated as if it has passed the consistent evaluation of the quality and efficacy of generic drugs.